Please use this identifier to cite or link to this item:
|Type:||Artigo de periódico|
|Title:||Brain SPECT imaging in Huntington's disease before and after therapy with olanzapine - Case report|
|Abstract:||Olanzapine, an atypical antipsychotic drug, was administered to a patient with Huntington's disease (HD) with marked choreiform movements. Brain SPECT with Tc-99m-HMPAO was performed before and after treatment. Brain SPECT imaging has been performed in patients with HD in order to determine the status of basal ganglia perfusion. The use of brain SPECT with Tc-99m-HMPAO before and after treatment in patients with HD has not been yet reported. The marked hypoperfusion of the basal ganglia on brain SPECT performed before therapy with olanzapine improved significantly after treatment.|
|Editor:||Assoc Arquivos De Neuro- Psiquiatria|
|Citation:||Arquivos De Neuro-psiquiatria. Assoc Arquivos De Neuro- Psiquiatria, v. 57, n. 3B, n. 863, n. 866, 1999.|
|Appears in Collections:||Unicamp - Artigos e Outros Documentos|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.